The Safety, Efficacy and Treatment Outcomes of a Combination of Low-Dose Decitabine Treatment in Patients With Recurrent Ovarian Cancer
OncoImmunology - United States
doi 10.1080/2162402x.2017.1323619
Full Text
Open PDFAbstract
Available in full text
Date
May 17, 2017
Authors
Publisher
Informa UK Limited